6.66
-0.03
(-0.37%)
At close: January 29 at 2:35:29 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
527,030.00
208,283.00
-10,867.00
596,975.00
1,110,336.00
Investing Cash Flow
921,118.00
-397,636.00
-1,978,823.00
-854,149.00
-858,115.00
Financing Cash Flow
-1,277,374.00
186,045.00
-173,493.00
2,297,679.00
-354,401.00
End Cash Position
667,409.00
529,577.00
547,979.00
2,675,611.00
579,647.00
Capital Expenditure
-317,885.00
-295,420.00
-375,560.00
-315,088.00
-362,560.00
Issuance of Debt
--
--
--
--
108,541.00
Repayment of Debt
--
-105,852.00
-104,287.00
-82,692.00
-79,037.00
Repurchase of Capital Stock
--
--
-3,459.00
-125,703.00
--
Free Cash Flow
209,145.00
-87,137.00
-386,427.00
281,887.00
747,776.00
12/31/2020 - 1/5/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CUP0.MU Chugai Pharmaceutical Co., Ltd.
20.80
+4.52%
AZN.ST AstraZeneca PLC
1,566.00
+0.64%
SAN.PA Sanofi
104.40
+0.75%
AZN.L AstraZeneca PLC
11,344.00
+0.27%
SNY Sanofi
54.34
+0.35%
AZN AstraZeneca PLC
70.76
-0.67%
AMGN Amgen Inc.
285.42
+0.49%
NOVO-B.CO Novo Nordisk A/S
607.30
+0.60%
MRK Merck & Co., Inc.
98.82
-0.13%